London, ON - Defibrillation-threshold (DFT) testing performed on a routine basis at ICD implantation is unlikely to significantly affect one- or five-year mortality, according to a statistical ...
Objective: This study was designed to test defibrillation threshold (DFT) with the least number of fibrillation inductions using upper limit of vulnerability (ULV) and to describe the most practical ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Routine defibrillation testing appears to be safe, but does not improve outcomes in patients ...
CHICAGO, IL—Defibrillation testing (DFT) is not always necessary in patients receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when using a scoring system that assesses the ...
Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...
Implantable cardioverter-defibrillators (ICDs) have transformed the management of patients at risk of sudden cardiac death by combining continuous rhythm monitoring with therapies that interrupt ...